Vårdprogram för barn och ungdomar med autismspektrumtillstånd

Rugino, Thomas A., Samsock, Teresa C. 2002. Levetiracetam in Autistic Children: An
Open.Label Study. Developmental and Behavioral Pediatrics. Vol.23, No.4.
Shea, Sarah et al.2004. Risperidone in the Treatment of Disruptive Behavioral Symtoms in
Children with Autistic and Other pervasive Developmental Disorders. Pediatrics.114:634-
641.
Simpson, Richard L. 2005. Autism Spectrum Disorders. Interventions and Treatments for
Children and Youth. Corwin Press.
Simpson, Richard L. 2005 Evidence-Based Practises and Students With Autism Spectrum
Disorders. Focus on Autism and other Developmental disabilities Vol.20, No.3, Fall Pages
140-149.
Simpson, Richard L. 2007. Evidence-Based Strategies and Students with Autism Spectrum
Disorders. South Carolina Autism Society Conferanse Columbia, SC. October 12.
Skuse, David H., Mandy, William P.L., Scourfield, Jane 2005. Measuring autistic traits:
heritability, reiability and validity of the Social and Communication Disorders Checklist.
British Journal of Psychiatry. 187:568-572.
Sokolski, Kenneth N. et al. 2004. Case Report; Selective Serotonin Reuptake Inhibitor-Related
Extrapyramidal Symtoms in Autistic Children. Journal of Child and Adolescent
Psychopharmacology. Vol.14. No.1.
Steffenburg, Suzanne 1990. Neurobiological Correlates of Autism. Doktorsavhandling.
Göteborgs universitet.
Stigler, K.A. et al. 2004. Case Report; Aripiprazole for Maladaptive Behavior in Pervasive
Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. Vol.14.
No. 3.
Trevathan, Edwin 2004. Seizures and Epilepsy Among Children With Language Regression
and Autistic Spectrum Disorders. Journal of Child Neurology. 19;S49.
Trillingsgaard, A., Dalby, M.A., Östergaard, J.R. Barn som är annorlunda. Dansk psykologisk
förlag 1997, Studentlitteratur 1999.
Troost, Pieter W. et al. 2006. Atomoxetine for Attention-Deficit/Hyperactivity Disorder
Symtoms in Children with Pervasive Developmental Disorders: A Pilot Study. Journal of
Child and Adolescent Psychopharmacology. Vol.16, No.5.
Tsai, Luke Y. 2009. Psychopharmacology in Autism. Psychosomatic Medicine. 61:651-665.
Tuchman, R., Moshé, S.L., Rapin, I. 2009. Convulsing toward the pathophysiology of autism.
Brain & Development. 31: 95-103,
Tuchman, R., Rapin, I. 2002. Epilepsy in autism. The Lancet Neurology. Vol.1.
Valicenti-McDermott, Maria R., Demb Howard. 2006. Clinical Effects and Adverse Reactions
of Off-Label Use of Aripiprazole in Children and Adolescents with Developmental
Disabilities. Journal of Child and Adolescent Psychopharmacology. Vol. 16, No 5.
Waclaw, Wanda1999. Barn med autism och Asperger syndrom. Futurum.
Walkup, John T. 2008. Pharmacologic Challenges Associated with Psychiatric Comorbidity.
American Academy of Child & Adolescent Psychiatry, 55 th Annual Meeting.
Referenser i form av Dokument
Autismspektrumtillstånd hos vuxna. Nationella psykiatrisamordnaren.
Assessment, diagnosis and clinical interventions for children and young people with autism
spectrum disorders. A national clinical guideline. Scottish Intercollegiate Guidelines Network
2007.
Bedömning av autismspektrumtillstånd - gemensam ram för verksamhetsområde NV. Stockholms
läns sjukvårdsområde, BUP-divisionen.
Farmakologisk behandling av depression hos barn och ungdomar - en uppdatering av kunskapsläget
- Bakgrundsdokumentation. Information från Läkemedelsverket 5:2005.
71